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Hepatic Transplantation in Wilson Disease* 
CARL G. GROTH, M.D.; RECBEN S. DUBOIS, M.D.; JACQUES CORMAN, M.D.; 
CHARLES HALGRIMSON, M.D.; DENIS O. RODGERSON, Ph.D. AND 
THOMAS E. STARZL, M.D., Ph.D. 
Two teen-age males with Wilson disease underwent orthotopic liver 
transplantation 32 and 12 months ago. One of the patients had normal 
serum ceruloplasmin and copper before as well as after operation. In the 
other case, these measures rose from low to normal values after 
transplantation. Both boys had increased cupriuresis after the operation. 
Biopsy specimens of the graft in one of the patients have shown no 
accumulation of copper. 
Wilson disease is an inborn error of metabolism 
characterized by an elevated copper content in the 
liver, brain and other organs. a low lewl of the 
copper-binding plasma protein ceruloplasmin. low 
total serum copper and ele\'ated urinary copper 
excretion. Pigmentation of the cornea with copper is 
visible on slit-lamp examination as the so-called 
Kayser-Fleischer ring. Any or all of these diagnostic 
criteria except the first mentioned may. however, be 
absent and the primary genet ic abnormality in 
Wilson disease remains obscure. 1 Earlier, clinical 
emphasis was usually on neurologic symptoms but in 
more recent years it has become apparent that 
almost all patients suffering from this disease have 
cirrhosis of the liver. 
Two teen-age boys with advanced Wilson disease 
have been treated with orthotopic hepat ic transplan-
tation at our institution. One of them was in terminal 
hepatic failure 2 while in the other the indication for 
the procedure was cirrhosis of the liver and se\'ere 
neurologic involvement not controlled by conven-
tional chelating therapy. 
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CASE REPORTS 
Case 1. Clinical Course. An ll-yr-old boy was admitted 
in July 1969, in hepatic precoma. The diagnosis of a liver 
disorder had been established at the age of P when an open 
liver biopsy showed "postnecrotic" cirrhosis. At that time 
serum copper and urinar:, copper excretion were normal. In 
April 1969, he was admitted to another hospital with 
symptoms of advanced liver disease and a biopsy again 
showed cirrhosis with the additional finding of Mallory 
bodies. This biopsy was interpreted as being consistent 
with Wilson disease. There were no Kayser-Fleischer rings 
and serum ceruloplasmin was within normal limits. When 
the patient was transferred to our institution 2 rna later. he 
had massive ascites. The serum bilirubin was 20.6 mg per 
100 m!. the serum albumin 1.5 gm per 100 m!' the 
prothrombin time 13S'C of normal and hlond ammonia 43:2 
f.lg nitrogen per 100 m!. Serum ceruloplasmin values were 
26-31 f.lg per 100 f.ll using an enzymatic assay (normal 2:2-43 
J.1.g per 100 ILl). Shortly after arrival the patient developed 
upper gastrointestinal hemorrhage and became agonal. At 
this time the patient's liver was removed and replaced with 
an orthotopic hepatic homograft from a cada\'eric donor. J 
Posttransplantation there was an immediate clearing of 
the sensorium. a fall in the serum bilirubin and blood 
ammonia levels, an increase in the total serum protein, and 
a normalization in the prothrombin time (Fig. 1). The 
patient was treated with an immunosuppressi\'e regimen 
that included azathioprine. prednisone and antilym-
phocyte globulin. Two early rejection episodes occurred, 1 
after a few days and the other after 3 wk. At the time of the 
2nd episode there was an extreme degree of hyper-
bilirubinemia and raIsed alkaline phosphatase (Fig. 1). 
Reversal of the rejection was followed by 1 yr of normal 
graft function but the succeeding yr again saw 2 episodes of 
moderate graft dysfunction. Presently, :2 yr and 8 rna after 
transplantation, the patient is clinically well with a biliru-
bin of 1.8 mg per 100 m!. He has had no demonstrable 
neurologic impairment after transplantation. No dietary 
limitations have been imposed and chelating agents have 
never been administered except during a brief test. 
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studies ut thf' Copper Metabolism after Transplanta-
linn. The patient'" diseased !i,'er contained 2J6 /-Ig copper 
per gm wet wt (normal less than 20). Following the 
trclDsplantat ion there was a massi,'e cupriuresis which 
declined to normal (less than 30 /-Ig per 24 hr) after several 
mo (Fig. 2). At the end of 7 mo a 3-day course of 
D-penicillamine 0.5 g/day) was given and there was a 
20-fold increase in urine copper excretion, which then 
rapidly returned to normal (Fig. 2). This increase is 
somewhat higher than that found in normal persons. From 
15 mo onwards urine excretion has again been slightly to 
moderately elevated (maximum 255 /-Ig per 24 hr). 
During the 2 yr and 8 mo of follow-up, serial serum 
ceruloplasmins have varied from 29,5 to 55 mg per 100 ml 
and coincidentally measured total serum coppers have 
ranged from 80 to 171 /-Ig per 100 ml (normal 70-118). 
Homograft biopsies obtained 6, 17 and 28 rno after 
transplantat ion contained 15, 13 and 7 /-Ig copper per gm 
wet wt. 
Ca.,<;e 2. Clinical course. This boy was found to have 
cirrhosis of the liver at 11 yr of age when he presented with 
ascites and a serum bilirubin of 9.5 rng per 100 ml. The 
following yr he showed an improvement but at.13 yr he was 
admitted to our institution following 2 episodes of hema-
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Fig. I. The course and the immunosuppressive treatment in 
Case 1. (Adapted from Lancet i:505, 1971.) 
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Fig. 2. Urinary excretion of copper after transplantation in 
('ase 1. (Aclapted from Lancet i:505, 1971.) 
temesis. At this time, Kayser-Fleischer ring-s were detected 
and serum ceruloplasmin was found to be distinctly 
subnormal at 1.0-1.7 mg per 100 ml. Total serum copper 
was low, 22.4-35 /-Ig per 100 ml, while the urinar.v excretion 
of the metal was elevated to 340-520 /-Ig per 24 hr. An open 
liver biopsy revealed "postnecrotic" cirrhosis, the copper 
content of the specimen was 392 /-Ig per gm wet wt. The 
diagnosis of Wilson disease was thus established and the 
patient was put on a low-copper diet and chel ating therapy 
was instituted with D-penicillamine and triethyline tetra-
mine dihydrochloride. 'In spite of increased cupriuresis the 
patient's neurologic status deteriorated, with athetot.ic 
movements, dvsarthria and mental disturbance. 
At 14 yr of -age, in March 1971, the patient underwent 
orthotopic hepatic transplantation. At this time t he serum 
bilirubin was 2.9 mg per 100 m\, serum albumin was 2.9 gm 
per 100 rnl, and prothrombin time 44'ic of normal. Postoper-
ative immunosuppression was the same as in Case 1, 
except that cyclophosphamide was given instead of azathi-
oprine during the 1st 9 mo. Following 1 mo of normal graft 
function, the serum bilirubin and the alkaline phosphatase 
rose rapidly to reach a maximum of 9.7 mg per 100 ml and 
952 IU, respectively (Fig. 3). The concurrent finding of 
Australia antigenemia suggested serum hepatitis. The 
bilirubin returned to normal in 1 mo while the alkaline 
phosphatase required several rno to recover (Fig. 3). 
Presently, 12 mo after transplantation, graft function is 
normal. 
During the 1st postoperative rna there was an improve-
ment in the patient's neurologic status but subsequently 
the symptoms from the nervous system have recurred 
intermittently. The Kayser-Fleischer rings have not 
changed during the 12 mo of follow-up. 
Studies of Copper Metabolism after Transplantation. 
The removed, native liver contained 184 /-Ig copper per gm 
wet wt. After the hepatic transplantation, serum cerulo-
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Fig. 3. The course and the immunosuppressive treatment in 
Case 2. 
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plasmin and copper rose. to reach normalleveb after :2 wk 
(Fig. 3). Urinary copper excretion fluctuated between 60 
and 600 ~g per 24 hr for 4 mo and then stabilized around 
100 ~g (Fig. 3), 
Discussion 
Since most of the symptoms and signs of Wilson 
disease were lacking in the first of these two patients. 
the diagnosis was missed and chelating therapy had 
never been instituted. Following operation, the high 
copper concentration in the native liver and the 
presence of Mallory bodies in the specimen estab-
lished the diagnosis. In addition, indirect evidence of 
extensive copper deposition in extrahepatic tissues 
was provided by the cupriuresis which followed 
operation. 
In contrast, the second patient had every classic 
manifestation of Wilson disease and low-copper diet 
and therapy with chelating drugs had been tried for 
more than 1 year. In spite of this, the patient's 
neurologic symptoms progressed to a stage where he 
was severely crippled. 
Following hepatic transplantation, both patients 
had an increased excretion of copper. In the second 
patient. low serum ceruloplasmin and copper rose to 
normal levels. Biopsy specimen of the graft in one of 
the patients has shown no accumulation ofthe metal. 
These findings are consistent with the hypothesis 
that the metabolic defect in Wilson disease is liver 
based. However, the facts that urinary copper excre-
tion has stayed moderately elevated in both cases, 
and that the Kayser-Fleischer rings of the second 
patient are unchanged, indicate that the ex-
trahepatic copper stores remain abnormal in these 
patipnts. 
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